Cannabis Extract CT-921 Has a High Efficacy–Adverse Effect Profile in a Neuropathic Pain Model

BACKGROUND: Legalization of cannabis encourages the development of specific cultivars to treat disease such as neuropathic pain. Because of the large number of cultivars, it is necessary to prioritize extracts before proceeding to clinical trials. PURPOSE: To compare extracts of two unique cannabis...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouhollahi, Elham, MacLeod, Bernard A, Barr, Alasdair M, Puil, Ernest
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443010/
https://www.ncbi.nlm.nih.gov/pubmed/32884239
http://dx.doi.org/10.2147/DDDT.S247584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443010/
https://www.ncbi.nlm.nih.gov/pubmed/32884239
http://dx.doi.org/10.2147/DDDT.S247584

Ejemplares similares